Stay updated on Durvalumab & Tremelimumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.

Latest updates to the Durvalumab & Tremelimumab in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedPage revision label updated to Revision: v3.3.4, replacing v3.3.3, as a minor UI/version change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedUpdated the study page by expanding the Locations section with additional site entries (Arizona, California, Colorado, Florida, Georgia, Illinois, Iowa, Kentucky, Maryland, Michigan, Missouri, Nebraska, New York, North Carolina, Ohio, Tennessee, Utah, Washington, and New Brunswick) and updating the revision to v3.3.3.SummaryDifference0.7%

- Check59 days agoChange DetectedPublications From PubMed section wording was updated to indicate automatic filling from PubMed. Revision labels were updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page no longer displays the government funding/operational status notice; core study content and details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check74 days agoChange DetectedThe location entry changed from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704' in the study's Locations list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedThe study details content appears unchanged between versions; there are no additions or deletions to arms, criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Durvalumab & Tremelimumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.